106 related articles for article (PubMed ID: 16211310)
1. Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Oncol Rep; 2005 Nov; 14(5):1365-9. PubMed ID: 16211310
[TBL] [Abstract][Full Text] [Related]
2. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683
[TBL] [Abstract][Full Text] [Related]
3. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
[TBL] [Abstract][Full Text] [Related]
4. Radiation reduces pirarubicin sensitivity in human cervical squamous cell carcinoma cells.
Tanaka T; Umesaki N
Oncol Rep; 2005 Jun; 13(6):1165-8. PubMed ID: 15870938
[TBL] [Abstract][Full Text] [Related]
5. Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2006; 27(3):243-6. PubMed ID: 16800250
[TBL] [Abstract][Full Text] [Related]
6. Radiation enhances cisplatin-sensitivity in human cervical squamous cancer cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):431-3. PubMed ID: 16122195
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of cancer cells that survived anticancer drug treatment.
Tanaka T; Chang L; Umesaki N; Ogita S
Osaka City Med J; 1997 Dec; 43(2):259-65. PubMed ID: 9540347
[TBL] [Abstract][Full Text] [Related]
9. Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas.
Tanaka T; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):411-4. PubMed ID: 16122190
[TBL] [Abstract][Full Text] [Related]
10. Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer.
Tsuchihashi Y; Abe S; Miyamoto L; Tsunematsu H; Izumi T; Hatano A; Okuno H; Yamane M; Yasuoka T; Ikeda Y; Tsuchiya K
Mol Pharm; 2020 Apr; 17(4):1049-1058. PubMed ID: 32068412
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.
Ling YH; Donato NJ; Perez-Soler R
Cancer Chemother Pharmacol; 2001 Jun; 47(6):473-80. PubMed ID: 11459199
[TBL] [Abstract][Full Text] [Related]
12. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N
Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
14. Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy.
Chen BM; Chen JY; Kao M; Lin JB; Yu MH; Roffler SR
Gynecol Oncol; 2000 Nov; 79(2):272-80. PubMed ID: 11063656
[TBL] [Abstract][Full Text] [Related]
15. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
[TBL] [Abstract][Full Text] [Related]
16. Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.
Fischel JL; Rostagno P; Formento P; Dubreuil A; Etienne MC; Milano G
Br J Cancer; 2001 Feb; 84(4):579-85. PubMed ID: 11207057
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].
Xu JM; Li YM; Wang Y; Zhao CH; Yuan SJ; Yang WW; Li ZQ; Han Y; Azzariti A; Paradiso A
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):578-82. PubMed ID: 17236550
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
Allegrini G; Goulette FA; Darnowski JW; Calabresi P
Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
[TBL] [Abstract][Full Text] [Related]
20. Influence of irinotecan and SN-38 on the irradiation response of WHO3 human oesophageal tumour cells under hypoxic conditions.
Van Rensburg CE; Slabbert JP; Bohm L
Anticancer Res; 2006; 26(1A):389-93. PubMed ID: 16475723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
